We are live on ! Find out more
SC

Sculptor Capital Portfolio holdings

AUM $9.61B
1-Year Est. Return 27.49%
This Fund
S&P 500
This Quarter Est. Return
+7.64%
1 Year Est. Return
+27.49%
3 Year Est. Return
+96.6%
5 Year Est. Return
+118.13%
10 Year Est. Return
+298.34%
AUM
$17.6B
AUM Growth
+$3.24B
Cap. Flow
+$1.6B
Cap. Flow %
9.1%
Top 10 Hldgs %
40.69%
Holding
467
New
155
Increased
40
Reduced
68
Closed
152

Sector Composition

Rank Sector Weight
1 Technology 10.11%
2 Consumer Discretionary 8.98%
3 Communication Services 8.74%
4 Energy 7.1%
5 Financials 4.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSIQ icon
251
Canadian Solar
CSIQ
$936M
$310K ﹤0.01%
25,300
-51,000
-67% -$660K
CSIQ icon
252
PUT
Canadian Solar
CSIQ
$936M
$310K ﹤0.01%
25,300
-51,000
-67% -$660K
ACIA
253
DELISTED
Acacia Communications Inc
ACIA
$287K ﹤0.01%
+4,900
New +$284K
RMTI icon
254
Rockwell Medical
RMTI
$27.6M
$275K ﹤0.01%
400
RMTI icon
255
PUT
Rockwell Medical
RMTI
$27.6M
$275K ﹤0.01%
400
-45
-10% -$29.7K
CRK icon
256
Comstock Resources
CRK
$3.82B
$264K ﹤0.01%
+28,600
New +$289K
CRK icon
257
PUT
Comstock Resources
CRK
$3.82B
$264K ﹤0.01%
+28,600
New +$289K
XONE
258
DELISTED
The ExOne Company
XONE
$248K ﹤0.01%
+24,300
New +$245K
XONE
259
PUT
DELISTED
The ExOne Company
XONE
$248K ﹤0.01%
+24,300
New +$245K
FIT
260
PUT
DELISTED
Fitbit, Inc. Class A common stock
FIT
$241K ﹤0.01%
40,700
-98,500
-71% -$625K
FIT
261
DELISTED
Fitbit, Inc. Class A common stock
FIT
$218K ﹤0.01%
36,800
-102,000
-73% -$647K
TVRD
262
PUT
Tvardi Therapeutics
TVRD
$23.8M
$213K ﹤0.01%
+322
New +$172K
PI icon
263
Impinj
PI
$3.97B
$206K ﹤0.01%
+6,800
New +$214K
PI icon
264
PUT
Impinj
PI
$3.97B
$206K ﹤0.01%
+6,800
New +$214K
ZYNE
265
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$193K ﹤0.01%
+9,600
New +$191K
ZYNE
266
PUT
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$193K ﹤0.01%
+9,600
New +$191K
TVRD
267
CALL
Tvardi Therapeutics
TVRD
$23.8M
$184K ﹤0.01%
+278
New +$149K
LNG icon
268
Cheniere Energy
LNG
$53.6B
$173K ﹤0.01%
+3,655
New +$169K
BX icon
269
Blackstone
BX
$106B
$159K ﹤0.01%
+5,346
New +$161K
DYN.WS
270
DELISTED
Dynegy Inc,
DYN.WS
$156K ﹤0.01%
3,728,945
XBIT icon
271
XBiotech
XBIT
$68.9M
$145K ﹤0.01%
+8,800
New +$115K
XBIT icon
272
PUT
XBiotech
XBIT
$68.9M
$145K ﹤0.01%
+8,800
New +$115K
KERX
273
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$109K ﹤0.01%
17,700
LXRX icon
274
Lexicon Pharmaceuticals
LXRX
$991M
$108K ﹤0.01%
+7,500
New +$111K
LXRX icon
275
PUT
Lexicon Pharmaceuticals
LXRX
$991M
$108K ﹤0.01%
+7,500
New +$111K

Similar funds

Sculptor Capital's Q1 2017 Portfolio in Review

As of Q1 2017, Sculptor Capital held 467 positions worth $17.6B, up 23% from $14.3B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Sculptor Capital deployed $1.6B of net new capital in Q1 2017, opening 155 new positions and adding to 40 existing holdings. Its largest new stake was Extraction Oil & Gas, Inc. Common Stock: 16,702,327 shares worth $310M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 11% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Delta Air Lines, an estimated $283M trimmed.

  • Sculptor Capital's largest Q1 2017 buy was Extraction Oil & Gas, Inc. Common Stock: 16,702,327 shares worth $310M.
  • Sculptor Capital added most to Bank of America in Q1 2017, an estimated $303M increase.
  • Sculptor Capital's biggest Q1 2017 reduction was Delta Air Lines, cutting an estimated $283M.
  • Sculptor Capital fully exited Activision Blizzard in Q1 2017, selling an estimated $326M.
  • Sculptor Capital's ten largest holdings make up 41% of its $17.6B portfolio in Q1 2017.
  • Sculptor Capital opened 155 new positions and closed 152 in Q1 2017.
  • Sculptor Capital's portfolio value rose 23% quarter-over-quarter to $17.6B.

Based on Sculptor Capital's 13F filing for Q1 2017, filed 12 May 2017.